Michael Heffernan
Founder at COLLEGIUM PHARMACEUTICAL, INC.
Net worth: 2 M $ as of 2024-03-30
Network origin in Michael Heffernan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Connecticut
139
| College/University | Other Consumer Services | 139 |
| Public Company | Pharmaceuticals: Major | 47 | |
| Unknown | 27 | ||
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Biotechnology | 24 | |
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Public Company | Biotechnology | 23 | |
| Subsidiary | Pharmaceuticals: Major | 19 | |
| Holding Company | Pharmaceuticals: Major | 16 | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark.
8
| Holding Company | Biotechnology | 8 |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI.
6
| Extinct | Pharmaceuticals: Major | 6 |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation.
5
| Holding Company | Pharmaceuticals: Major | 5 |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA.
4
| Holding Company | Biotechnology | 4 |
Onset Dermatologics LLC
 Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Heffernan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| VERICEL CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| Boston University | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Undergraduate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor General Counsel | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director/Board Member | |
| The University of Edinburgh | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| Princeton University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Graduate Degree | |
| New York University School of Medicine | College/University | Graduate Degree Doctorate Degree | |
| Mount Allison University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Ottawa | College/University | Doctorate Degree Doctorate Degree | |
Skyhawk Therapeutics, Inc.
 Skyhawk Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Skyhawk Therapeutics, Inc. discovers and develops small molecule therapeutics for RNA-based disease. It is developing drug candidates for cancer, neurological disease, and rare disease. The company was founded by William M. Hanley III and Kathleen McCarthy and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Operating Officer Chief Operating Officer | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree | |
| TERRASCEND CORP. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
| University of Virginia Darden School of Business | College/University | Director/Board Member Masters Business Admin | |
| PORTAGE BIOTECH INC. | Biotechnology | Founder Chief Executive Officer | |
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Founder Corporate Officer/Principal | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal |
Statistics
International
| United States | 39 |
| United Kingdom | 4 |
| Canada | 4 |
| Israel | 2 |
| Italy | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 581 |
| Corporate Officer/Principal | 255 |
| Independent Dir/Board Member | 180 |
| Chief Executive Officer | 96 |
| Chairman | 89 |
Most connected contacts
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Patrick Heron | 42 |
| John Childs | 40 |
| Peter Barrett | 38 |
| John Freund | 37 |
| Gregory Bailey | 36 |
| Mette Agger | 30 |
| Eric Aguiar | 29 |
| Declan Doogan | 28 |
| Lori Kunkel | 27 |
| Paul Wotton | 27 |
| Gino Santini | 26 |
| Steven Gilman | 25 |
| Robert Hugin | 24 |
| Anne VanLent | 23 |
- Stock Market
- Insiders
- Michael Heffernan
- Company connections
